Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

METRONIDAZOLE 0.75% LOTION

Metronidazole
$1.8499per ML

Strength

7.5 mg/mL

Manufacturer

Fougera Pharmaceuticals Inc.

NDC

00168038360

Classification

Generic

Dosage Form

LOTION

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

METRONIDAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA077197

On Market Since

5/24/2006

Pharmacological Classes

Nitroimidazole Antimicrobial
Nitroimidazoles

Price History

1W

0.0%

1M

-3.6%

3M

-6.9%

6M

+1.9%

1Y

-2.2%

3Y

-13.5%

5Y

-17.0%

All

-30.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

METRONIDAZOLE 250 MG TABLET
Generic
00904715661•Major Pharmaceuticals
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
23155065101•Heritage Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
23155065105•Heritage Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
58657093301•Method Pharmaceuticals LLC
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
58657093305•Method Pharmaceuticals LLC
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
69292020750•Amici Pharma, Inc
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
72578000701•Viona Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
72578000705•Viona Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
72578000721•Viona Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 500 MG TABLET
Generic
00904712661•Major Pharmaceuticals
$0.1022
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy